Explorer High Frequency , Sustained T Cell Responses to PARV 4 Suggest Viral Persistence In Vivo

[1]  O. Pybus,et al.  Epidemiology of Human Parvovirus 4 Infection in Sub-Saharan Africa , 2010, Emerging Infectious Diseases.

[2]  O. Pybus,et al.  Widespread Infection with Homologues of Human Parvoviruses B19, PARV4, and Human Bocavirus of Chimpanzees and Gorillas in the Wild , 2010, Journal of Virology.

[3]  H. Ellerbrok,et al.  High prevalence of porcine Hokovirus in German wild boar populations , 2010, Virology Journal.

[4]  K. Brown.  The expanding range of parvoviruses which infect humans , 2010, Reviews in medical virology.

[5]  S. Adjei,et al.  Novel Human Parvovirus 4 Genotype 3 in Infants, Ghana , 2010, Emerging infectious diseases.

[6]  P. Klenerman,et al.  High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies. , 2009, The Journal of infectious diseases.

[7]  A. Folgori,et al.  1051 PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES , 2009 .

[8]  R. Ponti,et al.  Detection of PARV4, genotypes 1 and 2, in healthy and pathological clinical specimens. , 2009, The new microbiologica.

[9]  Hendrik Streeck,et al.  The role of IFN-γ Elispot assay in HIV vaccine research , 2009, Nature Protocols.

[10]  P. Gallian,et al.  Human Parvovirus 4 in Kidney Transplant Patients, France , 2008, Emerging infectious diseases.

[11]  P. Klenerman,et al.  Direct ex vivo evaluation of long-lived protective antiviral memory B cell responses against hepatitis B virus. , 2008, The Journal of infectious diseases.

[12]  P. Simmonds,et al.  A third genotype of the human parvovirus PARV4 in sub-Saharan Africa. , 2008, The Journal of general virology.

[13]  T. Chieochansin,et al.  Parvovirus 4 (PARV4) in Serum of Intravenous Drug Users and Blood Donors , 2008, Infection.

[14]  P. Woo,et al.  Identification of novel porcine and bovine parvoviruses closely related to human parvovirus 4. , 2008, The Journal of general virology.

[15]  S. Baylis,et al.  Persistence of novel human parvovirus PARV4 in liver tissue of adults , 2008, Journal of medical virology.

[16]  G. McCaughan,et al.  Immunological Parameters Influencing Adaptive Immune Responses to the Hepatitis C Virus , 2008 .

[17]  J. Gerberding,et al.  Parvoviruses in Blood Donors and Transplant Patients, Italy , 2008 .

[18]  P. Simmonds,et al.  Parenteral Transmission of the Novel Human Parvovirus PARV4 , 2007, Emerging infectious diseases.

[19]  E. Delwart,et al.  Analysis of two human parvovirus PARV4 genotypes identified in human plasma for fractionation. , 2007, The Journal of general virology.

[20]  S. Antinori,et al.  Human parvovirus 4 in the bone marrow of Italian patients with AIDS , 2007, AIDS.

[21]  F. Hecht,et al.  Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals , 2007, Transfusion.

[22]  P. Simmonds,et al.  Comparison of Tissue Distribution, Persistence, and Molecular Epidemiology of Parvovirus B19 and Novel Human Parvoviruses PARV4 and Human Bocavirus , 2007, The Journal of infectious diseases.

[23]  S. Lucas,et al.  Parvoviruses PARV4/5 in hepatitis C virus-infected patient. , 2007, Emerging infectious diseases.

[24]  D. Strand,et al.  CD8 T Cells Control Cytomegalovirus Latency by Epitope-Specific Sensing of Transcriptional Reactivation , 2006, Journal of Virology.

[25]  A. Vaheri,et al.  Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Price,et al.  Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease. , 2006, The Journal of antimicrobial chemotherapy.

[27]  P. Klenerman,et al.  Aberrant cellular immune responses in humans infected persistently with parvovirus B19 , 2006, Journal of medical virology.

[28]  E. Delwart,et al.  Novel Parvovirus and Related Variant in Human Plasma , 2006, Emerging infectious diseases.

[29]  P. Klenerman,et al.  Prolonged Activation of Virus-Specific CD8+T Cells after Acute B19 Infection , 2005, PLoS medicine.

[30]  P. Klenerman,et al.  Sustained CD8+ T-Cell Responses Induced after Acute Parvovirus B19 Infection in Humans , 2005, Journal of Virology.

[31]  P. Simmonds,et al.  New DNA Viruses Identified in Patients with Acute Viral Infection Syndrome , 2005, Journal of Virology.

[32]  Todd M. Allen,et al.  High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. , 2004, Gastroenterology.

[33]  P. Klenerman,et al.  Virus‐specific CD8+ T lymphocytes within the normal human liver , 2004, European journal of immunology.

[34]  M. Bunce.  PCR-sequence-specific primer typing of HLA class I and class II alleles. , 2003, Methods in molecular biology.

[35]  M. Callan.  The evolution of antigen-specific CD8+ T cell responses after natural primary infection of humans with Epstein-Barr virus. , 2003, Viral immunology.

[36]  K. Brown,et al.  Human Parvovirus B19 , 2002, Clinical Microbiology Reviews.

[37]  S. Modrow,et al.  Antibody responses in parvovirus B19 infected patients. , 2002, Pathologie-biologie.

[38]  E. Heegaard,et al.  Prevalence of Parvovirus B19 and Parvovirus V9 DNA and Antibodies in Paired Bone Marrow and Serum Samples from Healthy Individuals , 2002, Journal of Clinical Microbiology.

[39]  R. Kotin,et al.  Biochemical Characterization of Junonia coenia Densovirus Nonstructural Protein NS-1 , 2002, Journal of Virology.

[40]  R. Rappuoli,et al.  Rationally designed strings of promiscuous CD4+ T cell epitopes provide help to Haemophilus influenzae type b oligosaccharide: a model for new conjugate vaccines , 2001, European journal of immunology.

[41]  P. Klenerman,et al.  Direct Ex Vivo Measurement of CD8+T-Lymphocyte Responses to Human Parvovirus B19 , 2001, Journal of Virology.

[42]  J. Bell,et al.  Functional Heterogeneity and High Frequencies of Cytomegalovirus-Specific CD8+ T Lymphocytes in Healthy Seropositive Donors , 2000, Journal of Virology.

[43]  M. Manns,et al.  Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C , 2000, Nature Medicine.

[44]  J. Schneider-Mergener,et al.  Target Structures of the CD8+-T-Cell Response to Human Cytomegalovirus: the 72-Kilodalton Major Immediate-Early Protein Revisited , 1999, Journal of Virology.

[45]  G. Siegl,et al.  Evidence for persistence of human parvovirus B19 DNA in bone marrow , 1997, Journal of medical virology.

[46]  A. McMichael,et al.  Rapid Effector Function in CD 8 1 Memory T Cells , 1997 .

[47]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[48]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[49]  W. Anderson,et al.  Structural and functional homology of parvovirus and papovavirus polypeptides. , 1987, The Journal of general virology.